Cargando…
Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines
Osteosarcoma (OS) is the most common primary bone tumor in children and young adults. Several studies have confirmed the involvement of the insulin-like growth factor (IGF) system in the regulation of OS cell proliferation and differentiation as well as in the protection of cells from chemotherapy....
Autores principales: | Garofalo, Cecilia, Capristo, Mariantonietta, Mancarella, Caterina, Reunevi, Hadas, Picci, Piero, Scotlandi, Katia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429561/ https://www.ncbi.nlm.nih.gov/pubmed/26029165 http://dx.doi.org/10.3389/fendo.2015.00074 |
Ejemplares similares
-
Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug
por: Garofalo, Cecilia, et al.
Publicado: (2013) -
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R
por: Mancarella, Caterina, et al.
Publicado: (2018) -
IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives
por: Mancarella, Caterina, et al.
Publicado: (2020) -
Novel Regulators of the IGF System in Cancer
por: Mancarella, Caterina, et al.
Publicado: (2021) -
Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
por: Mancarella, Caterina, et al.
Publicado: (2021)